Ichiro Hanamura Selected Research

Rituximab (Mabthera)

8/2022	Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.
9/2018	R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ichiro Hanamura Research Topics

Disease

21	Multiple Myeloma 01/2024 - 04/2003
16	Neoplasms (Cancer) 03/2024 - 10/2005
9	Leukemia 05/2021 - 12/2009
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021 - 12/2009
3	Disease Progression 01/2023 - 09/2006
3	Chromosome Aberrations (Chromosome Abnormalities) 06/2022 - 12/2009
2	Malignant Mesothelioma 07/2023 - 01/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 05/2019
2	Ulcer 08/2021 - 01/2019
2	Myeloid Leukemia (Leukemia, Myelocytic) 05/2021 - 01/2012
2	Fever (Fevers) 01/2020 - 05/2019
2	Genetic Translocation (Chromosomal Translocation) 12/2009 - 04/2003
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2024
1	Mucoepidermoid Carcinoma 01/2023
1	Thrombotic Thrombocytopenic Purpura 08/2022
1	Cytopenia 11/2021
1	Pancytopenia 11/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020
1	Hemolytic Anemia 10/2020
1	Splenic Hypoplasia 01/2020
1	Pneumococcal Infections 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Febrile Neutropenia 05/2019
1	Rheumatoid Arthritis 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2018
1	Infections 07/2017
1	Thrombosis (Thrombus) 02/2017

Drug/Important Bio-Agent (IBA)

7	Bortezomib (Velcade)FDA Link 10/2022 - 11/2015
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2006
4	Proteasome InhibitorsIBA 12/2023 - 01/2018
3	Immunomodulating AgentsIBA 12/2023 - 01/2018
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 05/2016
3	Messenger RNA (mRNA)IBA 12/2013 - 10/2005
3	Deoxyglucose (2 Deoxy D glucose)IBA 09/2013 - 11/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 02/2014
2	Adenosine Monophosphate (AMP)IBA 01/2024 - 06/2022
2	Protein Kinases (Protein Kinase)IBA 01/2024 - 10/2005
2	Serine (L-Serine)FDA Link 01/2024 - 01/2020
2	Rituximab (Mabthera)FDA Link 08/2022 - 09/2018
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2021
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2021
2	venetoclaxIBA 10/2021 - 12/2020
2	Methotrexate (Mexate)FDA LinkGeneric 08/2021 - 01/2019
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021 - 04/2003
2	Toll-Like Receptor 1IBA 07/2017 - 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	Dynamins (Dynamin)IBA 01/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	MMEIBA 07/2023
1	KN 93IBA 07/2023
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Lenalidomide (CC 5013)FDA Link 10/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2022
1	GlucocorticoidsIBA 08/2022
1	CopperIBA 11/2021
1	daratumumabIBA 10/2021
1	IntegrinsIBA 07/2021
1	Alemtuzumab (Campath)FDA Link 05/2021
1	fms-Like Tyrosine Kinase 3IBA 05/2021
1	Inosine Triphosphate (ITP)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	SteroidsIBA 10/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2020
1	OTS514IBA 01/2020
1	PDZ-binding kinaseIBA 01/2020
1	AsparagineIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	NK Cell Lectin-Like Receptor Subfamily KIBA 06/2019
1	Doripenem FDA Link 05/2019
1	Meropenem (Merrem)FDA LinkGeneric 05/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2018
1	Cyclin DIBA 12/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018
1	Thalidomide (Thalomid)FDA Link 05/2018
1	Toll-Like Receptor 2IBA 07/2017
1	Toll-Like Receptor 4IBA 07/2017

Therapy/Procedure

11	Therapeutics 01/2023 - 09/2006
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 10/2020 - 01/2012
4	Stem Cell Transplantation 12/2023 - 09/2006
1	Aftercare (After-Treatment) 08/2022
1	Salvage Therapy 08/2022
1	Plasma Exchange 08/2022
1	Immunotherapy 12/2020
1	Molecular Targeted Therapy 10/2020
1	Hematopoietic Stem Cell Transplantation 10/2019
1	Radiotherapy 09/2019